0.00Open0.00Pre Close0 Volume0 Open Interest50.00Strike Price0.00Turnover0.00%IV-27.27%PremiumJan 17, 2025Expiry Date18.75Intrinsic Value100Multiplier24DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma3.70Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Ormat Technologies Stock Discussion
Apple has an average investment rating of outperform among analysts polled by Capital IQ, with price targets ranging from $116 to $210.
Citigroup Upgrades $Norfolk Southern (NSC.US)$to Buy From Neutral, Adjusts Price Target to $257 From $226
Norfolk Southern has an average rating of outperform and price targets ranging from $174 to $288, according to analysts ...
Gap Ups
1. $Bath & Body Works (BBWI.US)$ - up 7.8%
2. $Lloyds Banking (LYG.US)$ - up 0.48%
3. $Cisco (CSCO.US)$ - up 0.4%
Gap Downs
1. $Ormat Technologies (ORA.US)$ - down 5.45%
2. $Cloudflare (NET.US)$ - down 3.46%
3. $Spotify Technology (SPOT.US)$ - down 2.62%
4. $Gitlab (GTLB.US)$ - dow...
• $La-Z-Boy (LZB.US)$ +9.3% (In reaction to earnings/guidance)
• $Enanta Pharmaceuticals (ENTA.US)$ +6.7% (ENTA files patent infringement lawsuit against $Pfizer (PFE.US)$)
• $Ikena Oncology (IKNA.US)$ +6.6% (granted Fast Track designation for IK-930)
• $BridgeBio Pharma (BBIO.US)$ +6.4% (Announces Early Positive Data for BBP-812)
• $Krystal Biotech (KRYS.US)$ +5% (submits Biologies License Application to FDA seeking approval of B-V...
No comment yet